Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
HEB > SEC Filings for HEB > Form 8-K on 29-Jul-2013All Recent SEC Filings

Show all filings for HEMISPHERX BIOPHARMA INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for HEMISPHERX BIOPHARMA INC


29-Jul-2013

Change in Directors or Principal Officers, Financial Statements and Exhi


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective July 23, 2013, the Board of Directors of Hemispherx Biopharma, Inc. (the "Company") approved the appointment of Peter W. Rodino III, Esq. as a Director of the Company. Mr. Rodino will serve as a Director until the Company's next annual meeting of shareholders. Mr. Rodino was also appointed as Chairman and Financial Expert of the Audit Committee, a member of the Compensation Committee and a member of the Governance and Nomination Committee of the Board of Directors. Mr. Rodino had previously acted as a consultant to the Company. In addition, Dr. Iraj Kiani, a long time independent Director of the Company, was appointed to be the Board's Lead Director. These changes were the result of the recent resignation due to health reasons of Richard C. Piani.

On July 29, 2013, the Company issued a press release announcing the appointment of Mr. Rodino. A copy of this press release is attached hereto as Exhibit 99.1.



Item 9.01. Financial Statements and Exhibits.

(c) Exhibits:

99.1 Press Release dated July 29, 2013


  Add HEB to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for HEB - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.